PATTERNOX

PATTERNOX (#LSIEurope24 Innovator) is revolutionizing the early detection of skin cancer and cosmetic abnormalities with its groundbreaking scanner, PatScope. Motivated by his mother's battle with skin cancer, Dr. Aharon developed this innovative technology to detect lesion distortions, an early warning sign of skin abnormalities and skin cancer. PatScope uses a unique imaging system and a machine learning algorithm to provide precise and reproducible results, allowing for early diagnosis and intervention. Current methods for detecting cosmetic concerns or skin cancer rely on color changes at a late stage of the lesion or mole, leading to late diagnoses and high mortality rates. There is no method to prioritize the removal of multiple lesions, and critical information around the lesion is often neglected. Patternox's PatScope imager reveals lesion distortions at an early stage, which are precursors to skin cancer and cosmetic abnormalities. This unique imaging technique includes information about the surrounding distortions of a lesion, aiding in understanding the risk and prioritizing which lesion to remove first. We’re excited to welcome Dr. Ofir Aharon, CEO of Patternox to present at LSI Europe ‘24 this September 16-20 in Sintra, Portugal. Join us in Portugal to meet with Dr. Ofir Aharon and learn more about Patternox.

PATTERNOX (#LSIEurope24 Innovator) is revolutionizing the early detection of skin cancer and cosmetic abnormalities with its groundbreaking scanner, PatScope. Motivated by his mother's battle with skin cancer, Dr. Aharon developed this innovative technology to detect lesion distortions, an early warning sign of skin abnormalities and skin cancer. PatScope uses a unique imaging system and a machine learning algorithm to provide precise and reproducible results, allowing for early diagnosis and intervention. Current methods for detecting cosmetic concerns or skin cancer rely on color changes at a late stage of the lesion or mole, leading to late diagnoses and high mortality rates. There is no method to prioritize the removal of multiple lesions, and critical information around the lesion is often neglected. Patternox's PatScope imager reveals lesion distortions at an early stage, which are precursors to skin cancer and cosmetic abnormalities. This unique imaging technique includes information about the surrounding distortions of a lesion, aiding in understanding the risk and prioritizing which lesion to remove first. We’re excited to welcome Dr. Ofir Aharon, CEO of Patternox to present at LSI Europe ‘24 this September 16-20 in Sintra, Portugal. Join us in Portugal to meet with Dr. Ofir Aharon and learn more about Patternox.

PATTERNOX (#LSIEurope24 Innovator) is revolutionizing the early detection of skin cancer and cosmetic abnormalities with its groundbreaking scanner, PatScope. Motivated by his mother's battle with skin cancer, Dr. Aharon developed this innovative technology to detect lesion distortions, an early warning sign of skin abnormalities and skin cancer. PatScope uses a unique imaging system and a machine learning algorithm to provide precise and reproducible results, allowing for early diagnosis and intervention. Current methods for detecting cosmetic concerns or skin cancer rely on color changes at a late stage of the lesion or mole, leading to late diagnoses and high mortality rates. There is no method to prioritize the removal of multiple lesions, and critical information around the lesion is often neglected. Patternox's PatScope imager reveals lesion distortions at an early stage, which are precursors to skin cancer and cosmetic abnormalities. This unique imaging technique includes information about the surrounding distortions of a lesion, aiding in understanding the risk and prioritizing which lesion to remove first. We’re excited to welcome Dr. Ofir Aharon, CEO of Patternox to present at LSI Europe ‘24 this September 16-20 in Sintra, Portugal. Join us in Portugal to meet with Dr. Ofir Aharon and learn more about Patternox.